Results 321 to 330 of about 2,660,626 (386)
Some of the next articles are maybe not open access.
American Journal of Gastroenterology, 2003
The aim of the present study was to assess the correlation of Triage Micro Clostridium difficile Panel and toxin B cytotoxicity assay with the clinical diagnosis of C. difficile diarrhea.The subjects evaluated were 98 patients with diarrhea for whom stool was submitted for testing for C. difficile.
Scott D, Lee +4 more
openaire +3 more sources
The aim of the present study was to assess the correlation of Triage Micro Clostridium difficile Panel and toxin B cytotoxicity assay with the clinical diagnosis of C. difficile diarrhea.The subjects evaluated were 98 patients with diarrhea for whom stool was submitted for testing for C. difficile.
Scott D, Lee +4 more
openaire +3 more sources
American Journal of Clinical Pathology, 1983
An assay for circulating immune complexes (CIC) that is adaptable to a routine clinical laboratory is described. This solid phase C1q (SP C1q) enzyme immunoassay (EIA) uses commercially available reagents and is reproducible with CV% of less than 20% in the abnormal range.
K, James +3 more
openaire +2 more sources
An assay for circulating immune complexes (CIC) that is adaptable to a routine clinical laboratory is described. This solid phase C1q (SP C1q) enzyme immunoassay (EIA) uses commercially available reagents and is reproducible with CV% of less than 20% in the abnormal range.
K, James +3 more
openaire +2 more sources
Journal of Clinical Virology, 2008
Centers for Disease Control (CDC) guidelines require confirmation of hepatitis C virus (HCV) screening-test-positive sera with a low signal/cut-off (S/CO) ratio by recombinant immunoblot or PCR. The UK Health Protection Agency has suggested that a second enzyme immunoassay (EIA) could be used as an alternative for confirmation in non-immunocompromised ...
Pieter, Vermeersch +2 more
openaire +2 more sources
Centers for Disease Control (CDC) guidelines require confirmation of hepatitis C virus (HCV) screening-test-positive sera with a low signal/cut-off (S/CO) ratio by recombinant immunoblot or PCR. The UK Health Protection Agency has suggested that a second enzyme immunoassay (EIA) could be used as an alternative for confirmation in non-immunocompromised ...
Pieter, Vermeersch +2 more
openaire +2 more sources
Rinsho byori. The Japanese journal of clinical pathology, 2014
The measurement of antinuclear antibodies (ANA) is used for screening of connective tissue diseases (CTD) in the laboratory. ANA detection is performed by indirect immunofluorescence (IF) assay on HEp-2 cells from human larynx carcinoma. However, it lacks specificity for the identification of specific diseases and antigen reactivity.
Naomi, Watanabe +5 more
openaire +1 more source
The measurement of antinuclear antibodies (ANA) is used for screening of connective tissue diseases (CTD) in the laboratory. ANA detection is performed by indirect immunofluorescence (IF) assay on HEp-2 cells from human larynx carcinoma. However, it lacks specificity for the identification of specific diseases and antigen reactivity.
Naomi, Watanabe +5 more
openaire +1 more source
Serum enzyme tests in diseases of the liver and biliary tree.
American Journal of Clinical Pathology, 1978G. Ellis +3 more
semanticscholar +1 more source
Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 1999
In the Croatian transfusion medicine, no general agreement has yet been achieved whether red blood cell (RBC) Rhesus (Rh) antibodies detected during pregnancy only by enzyme tests can cause hemolytic disease of the newborn (HDN). Results of the detection of clinically significant RBC antibodies by low-ionic-strength additive solution antiglobulin test (
Hundrić Hašpl, Željka +2 more
openaire +2 more sources
In the Croatian transfusion medicine, no general agreement has yet been achieved whether red blood cell (RBC) Rhesus (Rh) antibodies detected during pregnancy only by enzyme tests can cause hemolytic disease of the newborn (HDN). Results of the detection of clinically significant RBC antibodies by low-ionic-strength additive solution antiglobulin test (
Hundrić Hašpl, Željka +2 more
openaire +2 more sources
Evaluation of provocative blood enzyme tests employed in diagnosis of pancreatic disease.
A M A Archives of Internal Medicine, 1954D. Dreiling, A. Richman
semanticscholar +1 more source
Acta medica Croatica, 1999
In the Croatian transfusion medicine, no general agreement has yet been achived wheather red blood cell (RBC) Rhesus (Rh) antibodies detected durin pregnancy only by enzyme tests can cause hemolytic disease of the newborn (HDN).
Hundrić-Hašpl, Željka +1 more
openaire
In the Croatian transfusion medicine, no general agreement has yet been achived wheather red blood cell (RBC) Rhesus (Rh) antibodies detected durin pregnancy only by enzyme tests can cause hemolytic disease of the newborn (HDN).
Hundrić-Hašpl, Željka +1 more
openaire
Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests
Clinical Pharmacology & Therapeutics, 2005Tommy, Andersson +7 more
openaire +2 more sources
Journal of Inherited Metabolic Disease, 2012
Caroline Regnery +11 more
semanticscholar +1 more source
Caroline Regnery +11 more
semanticscholar +1 more source